血管内皮生长因子在雄激素性脱发中的研究进展

doi:10.35541/cjd.20220240

中华皮肤科杂志 ›› 2023, e20220240.doi: 10.35541/cjd.20220240

血管内皮生长因子在雄激素性脱发中的研究进展

张莉¹ 宋秀祖²

¹浙江中医药大学附属杭州第三医院皮肤科，杭州 310009；²杭州市第三人民医院皮肤科，杭州 310009

收稿日期:2022-04-08 修回日期:2022-09-07 发布日期:2023-07-20
通讯作者: 宋秀祖 E-mail:songxiuzu@sina.com
基金资助:
国家自然科学基金（81872517）

Role of vascular endothelial growth factor in androgenetic alopecia

Zhang Li¹, Song Xiuzu²

¹Department of Dermatology, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou 310009, China; ²Department of Dermatology, Hangzhou Third People′s Hospital, Hangzhou 310009, China

Received:2022-04-08 Revised:2022-09-07 Published:2023-07-20
Contact: Song Xiuzu E-mail:songxiuzu@sina.com
Supported by:
National Natural Science Foundation of China（81872517）

摘要/Abstract

摘要： 【摘要】雄激素性脱发主要病理特点是渐进性的毛囊微小化，毛囊周围血管改变与其密切相关。血管内皮生长因子通过与毛乳头细胞及毛囊干细胞相互作用，促进毛囊周围血管形成，增加毛囊营养供应从而促进毛发生长。本文综述血管内皮生长因子在雄激素性脱发中的研究进展。

关键词: 秃发, 血管内皮生长因子类, 治疗

Abstract: 【Abstract】 The main pathological feature of androgenetic alopecia is the progressive miniaturization of hair follicles, which is closely related to vascular changes around hair follicles. Vascular endothelial growth factor interacts with dermal papilla cells and hair follicle stem cells to promote the formation of blood vessels around hair follicles, and to increase the nutrient supply to hair follicles, thereby promoting hair growth. This review summarizes research progress in the role of vascular endothelial growth factor in androgenetic alopecia.

Key words: Alopecia, Vascular endothelial growth factors, Therapy

张莉宋秀祖. 血管内皮生长因子在雄激素性脱发中的研究进展[J]. 中华皮肤科杂志, 2023,e20220240. doi:10.35541/cjd.20220240

Zhang Li, Song Xiuzu. Role of vascular endothelial growth factor in androgenetic alopecia[J]. Chinese Journal of Dermatology,2023,e20220240. doi:10.35541/cjd.20220240

参考文献 36

［1］	Zhou Y, Yu S, Zhao J, et al. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia［J］. Biomed Res Int, 2020,2020:1501893. doi: 10.1155/2020/150 1893.
［2］	Faghihi G, Iraji F, Siadat AH, et al. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia［J/OL］. J Cosmet Dermatol, 2022［2022⁃05⁃30］. https://www.ncbi.nlm.nih.gov/pubmed/35152531. doi: 10.1111/jocd.14788.
［3］	Kozlowska U, Blume⁃Peytavi U, Kodelja V, et al. Expression of vascular endothelial growth factor （VEGF） in various compartments of the human hair follicle［J］. Arch Dermatol Res, 1998,290（12）:661⁃668. doi: 10.1007/s004030050370.
［4］	Chew E, Tan J, Bahta AW, et al. Differential expression between human dermal papilla cells from balding and non⁃balding scalps reveals new candidate genes for androgenetic alopecia［J］. J Invest Dermatol, 2016,136（8）:1559⁃1567. doi: 10.1016/j.jid.2016.03. 032.
［5］	Mecklenburg L, Tobin DJ, Müller⁃Röver S, et al. Active hair growth （anagen） is associated with angiogenesis［J］. J Invest Dermatol, 2000,114（5）:909⁃916. doi: 10.1046/j.1523⁃1747.2000. 00954.x.
［6］	Deng Z, Chen M, Liu F, et al. Androgen receptor⁃mediated paracrine signaling induces regression of blood vessels in the dermal papilla in androgenetic alopecia［J］. J Invest Dermatol, 2022,142（8）:2088⁃2099.e9. doi: 10.1016/j.jid.2022.01.003.
［7］	Chen P, Miao Y, Zhang F, et al. Tissue engineering ECM⁃enriched controllable vascularized human microtissue for hair regenerative medicine using a biomimetic developmental approach［J］. J Adv Res, 2022,38:77⁃89. doi: 10.1016/j.jare.2021. 09.010.
［8］	Park S, Kang W, Choi D, et al. Nonanal stimulates growth factors via cyclic adenosine monophosphate （cAMP） signaling in human hair follicle dermal papilla cells［J］. Int J Mol Sci, 2020,21（21）:8054. doi: 10.3390/ijms21218054.
［9］	Lachgar S, Charveron M, Gall Y, et al. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells［J］. Br J Dermatol, 1998,138（3）:407⁃411. doi: 10.1046/j.1365⁃2133.1998.02115.x.
［10］	Lachgar S, Moukadiri H, Jonca F, et al. Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells［J］. J Invest Dermatol, 1996,106（1）:17⁃23. doi: 10.1111/1523⁃1747.ep12326964.
［11］	Bassino E, Gasparri F, Giannini V, et al. Paracrine crosstalk between human hair follicle dermal papilla cells and microvascular endothelial cells［J］. Exp Dermatol, 2015,24（5）:388⁃390. doi: 10.1111/exd.12670.
［12］	Goldman CK, Tsai JC, Soroceanu L, et al. Loss of vascular endothelial growth factor in human alopecia hair follicles［J］. J Invest Dermatol, 1995,104（5 Suppl）:18S⁃20S. doi: 10.1038/jid. 1995.40.
［13］	Zhang X, Zhou D, Ma T, et al. Vascular endothelial growth factor protects CD200⁃rich and CD34⁃positive hair follicle stem cells against androgen⁃induced apoptosis through the phosphoinositide 3⁃kinase/Akt pathway in patients with androgenic alopecia［J］. Dermatol Surg, 2020,46（3）:358⁃368. doi: 10.1097/DSS.0000000 000002091.
［14］	Andjelkov K, Eremin II, Korac A. Different levels of EGF, VEGF, IL⁃6, MCP⁃1, MCP⁃3, IP⁃10, eotaxin and MIP⁃1α in the adipose⁃derived stem cell secretome in androgenetic alopecia［J］. Exp Dermatol, 2022,31（6）:936⁃942. doi: 10.1111/exd.14548.
［15］	Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF⁃mediated angiogenesis［J］. J Clin Invest, 2001,107（4）:409⁃417. doi: 10.1172/JCI11317.
［16］	Kapoor R, Shome D. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth ⁃ safety and efficacy evaluation in a first⁃in⁃man pilot clinical study［J］. J Cosmet Laser Ther, 2018,20（6）:369⁃379. doi: 10.1080/14764172.2018.1439965.
［17］	Lee YB, Eun YS, Lee JH, et al. Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: a pilot study［J］. J Dermatol, 2013,40（1）:81⁃83. doi: 10.1111/j.1346⁃8138.2012.01680.x.
［18］	Zimber MP, Ziering C, Zeigler F, et al. Hair regrowth following a Wnt⁃ and follistatin containing treatment: safety and efficacy in a first⁃in⁃man phase 1 clinical trial［J］. J Drugs Dermatol, 2011,10（11）:1308⁃1312.
［19］	Siah TW, Guo H, Chu T, et al. Growth factor concentrations in platelet⁃rich plasma for androgenetic alopecia: an intra⁃subject, randomized, blinded, placebo⁃controlled, pilot study［J］. Exp Dermatol, 2020,29（3）:334⁃340. doi: 10.1111/exd.14074.
［20］	Li ZJ, Choi HI, Choi DK, et al. Autologous platelet⁃rich plasma: a potential therapeutic tool for promoting hair growth［J］. Dermatol Surg, 2012,38（7 Pt 1）:1040⁃1046. doi: 10.1111/j.1524⁃4725.2012.02394.x.
［21］	Steward EN, Patel H, Pandya H, et al. Efficacy of platelet⁃rich plasma and concentrated growth factor in treating androgenetic alopecia ⁃ a retrospective study［J］. Ann Maxillofac Surg, 2020,10（2）:409⁃416. doi: 10.4103/ams.ams_154_19.
［22］	Pakhomova EE, Smirnova IO. Comparative evaluation of the clinical efficacy of PRP⁃therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia［J］. Int J Mol Sci, 2020,21（18）:6516. doi: 10.3390/ijms21186516.
［23］	Lee SH, Ok SH, Kang D, et al. Nitric oxide⁃dependent vasodilation induced by minoxidil in isolated rat aorta［J］. Gen Physiol Biophys, 2021,40（3）:197⁃206. doi: 10.4149/gpb_2021012.
［24］	Oh HA, Kwak J, Kim BJ, et al. Migration inhibitory factor in conditioned medium from human umbilical cord blood⁃derived mesenchymal stromal cells stimulates hair growth［J］. Cells, 2020,9（6）:1344. doi: 10.3390/cells9061344.
［25］	Chen X, Liu B, Li Y, et al. Dihydrotestosterone regulates hair growth through the Wnt/β⁃catenin pathway in C57BL/6 mice and in vitro organ culture［J］. Front Pharmacol, 2019,10:1528. doi: 10.3389/fphar.2019.01528.
［26］	Li M, Marubayashi A, Nakaya Y, et al. Minoxidil⁃induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil［J］. J Invest Dermatol, 2001,117（6）:1594⁃1600. doi: 10.1046/j.0022⁃202x.2001.01570.x.
［27］	Meephansan J, Thummakriengkrai J, Ponnikorn S, et al. Efficacy of topical tofacitinib in promoting hair growth in non⁃scarring alopecia: possible mechanism via VEGF induction［J］. Arch Dermatol Res, 2017,309（9）:729⁃738. doi: 10.1007/s00403⁃017⁃1777⁃5.
［28］	Iwabuchi T, Ogura K, Tamba K, et al. Cepharanthine induces the proliferation of human dermal papilla cells and stimulates vascular endothelial growth factor expression through increased intracellular calcium mobilization and hypoxia⁃inducible factor activation［J］. Clin Exp Dermatol, 2021,46（4）:694⁃703. doi: 10. 1111/ced.14533.
［29］	Shin JY, Choi YH, Kim J, et al. Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells［J］. BMC Complement Med Ther, 2020,20（1）:144. doi: 10. 1186/s12906⁃020⁃02940⁃5.
［30］	Kim BH, Lee MJ, Lee WY, et al. Hair growth stimulation effect of Centipeda minima extract: identification of active compounds and anagen⁃activating signaling pathways［J］. Biomolecules, 2021,11（7）:976. doi: 10.3390/biom11070976.
［31］	Choi M, Choi SJ, Jang S, et al. Shikimic acid, a mannose bioisostere, promotes hair growth with the induction of anagen hair cycle［J］. Sci Rep, 2019,9（1）:17008. doi: 10.1038/s41598⁃019⁃53612⁃5.
［32］	Kim J, Shin JY, Choi YH, et al. Hair growth promoting effect of Hottuynia cordata extract in cultured human hair follicle dermal papilla cells［J］. Biol Pharm Bull, 2019,42（10）:1665⁃1673. doi: 10.1248/bpb.b19⁃00254.
［33］	Hwang D, Lee H, Lee J, et al. Micro⁃current stimulation has potential effects of hair growth⁃promotion on human hair follicle⁃derived papilla cells and animal model［J］. Int J Mol Sci, 2021,22（9）:4361. doi: 10.3390/ijms22094361.
［34］	Nakamura T, Yamamura H, Park K, et al. Naturally occurring hair growth peptide: water⁃soluble chicken egg yolk peptides stimulate hair growth through induction of vascular endothelial growth factor production［J］. J Med Food, 2018,21（7）:701⁃708. doi: 10.1089/jmf.2017.4101.
［35］	Wang Z, Nan W, Si H, et al. Pantothenic acid promotes dermal papilla cell proliferation in hair follicles of American minks via inhibitor of DNA binding 3/Notch signaling pathway［J］. Life Sci, 2020,252:117667. doi: 10.1016/j.lfs.2020.117667.
［36］	Inan Yuksel E, Demir B, Cicek D, et al. Sodium pentaborate pentahydrate promotes hair growth through the Wnt/β⁃catenin pathway and growth factors［J］. J Trace Elem Med Biol, 2022,73:127007. doi: 10.1016/j.jtemb.2022.127007.

[1]	宋雨晴杨楠刘琳琳冯子仪韩世新周梅娟. [开放获取] 皮肤磨削术治疗家族性良性慢性天疱疮6例临床观察[J]. 中华皮肤科杂志, 2024, 0(4): 20220278-e20220278.
[2]	宗杨永怡马楚君苏忠兰. 银屑病生物制剂治疗后湿疹化发生机制及应对策略[J]. 中华皮肤科杂志, 2024, 0(3): 20220578-e20220578.
[3]	王煜坤刘洁. 深度学习在非肿瘤性皮肤病中的应用进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220660-e20220660.
[4]	戴叶芹宋秀祖. 毛囊及毛囊细胞移植在白癜风治疗中的应用进展[J]. 中华皮肤科杂志, 2024, 0(3): 20230274-e0230274.
[5]	中国医学科学院皮肤病医院中国疾病预防控制中心性病控制中心中华医学会皮肤性病学分会性病学组中国康复医学会皮肤病康复专业委员会. [开放获取] 中国生殖支原体感染诊疗专家共识（2024）[J]. 中华皮肤科杂志, 2024, 57(3): 201-208.
[6]	王千秋郑晓丽杜方智张栩. 遏制梅毒传播：新形势与新策略[J]. 中华皮肤科杂志, 2024, 57(3): 209-212.
[7]	中华医学会皮肤性病学分会中国疾病预防控制中心性病控制中心中国医师协会皮肤科医师分会中国康复医学会皮肤病康复专业委员会. 中国沙眼衣原体泌尿生殖道感染临床诊疗指南（2024）[J]. 中华皮肤科杂志, 2024, 57(3): 193-200.
[8]	张瑾陈绍椿尹跃平. 耐药淋球菌的备选治疗方案[J]. 中华皮肤科杂志, 2024, 57(3): 272-275.
[9]	中国医师协会皮肤科医师分会中华医学会皮肤性病学分会中国医疗保健国际交流促进会皮肤医学分会疑难重症及罕见病国家重点实验室国家皮肤与免疫疾病临床医学研究中心. 特应性皮炎治疗药物应用管理专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 97-108.
[10]	中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 109-118.
[11]	葛新红马迎东焦亚宁刘玲玲周镁紫薇李博文. 532 nm皮秒激光治疗面部早期脂溢性角化病的疗效和安全性分析[J]. 中华皮肤科杂志, 2024, 0(2): 20230061-e20230061.
[12]	中国中西医结合学会皮肤性病专业委员会皮肤肿瘤学组中国抗癌协会黑色素瘤专业委员会. [开放获取] 人干扰素α1b治疗黑色素瘤专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(1): 1-7.
[13]	古丽孜巴·图尔荪屈园园. Janus激酶-信号转导及转录激活因子信号通路抑制剂在白癜风治疗中的新进展[J]. 中华皮肤科杂志, 2024, 57(1): 71-75.
[14]	张倩张金娥郭森宋璞高琳李春英. CO2点阵激光联合氟尿嘧啶/复方倍他米松注射液导入治疗白癜风的临床观察[J]. 中华皮肤科杂志, 2024, 57(1): 34-38.
[15]	宣依洁杨奕雯王琛徐中奕项蕾红张成锋. 进展期非节段型白癜风患者对系统糖皮质激素治疗反应的相关影响因素研究[J]. 中华皮肤科杂志, 2024, 57(1): 17-22.

血管内皮生长因子在雄激素性脱发中的研究进展

Role of vascular endothelial growth factor in androgenetic alopecia

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 15

Metrics

本文评价

推荐阅读 10